Home/Rapidemic/Peter Rahfeld
PR

Peter Rahfeld

Science & Operations Officer

Rapidemic

Therapeutic Areas

Rapidemic Pipeline

DrugIndicationPhase
Rapid Molecular STI TestChlamydia trachomatis and Neisseria gonorrhoeae infectionPre-clinical